Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

4th ANNUAL LEADERS IN LIFE SCIENCES BREAKFAST ROUNDTABLE BRINGS KEY INDUSTRY PLAYERS TOGETHER

LevLane

The 4 th Annual Leaders in Life Sciences breakfast roundtable will take place at 7:00AM – 9:00AM EST on May 18, 2021, hosted by LevLane, Boston Healthcare Associates, and Buchanan Ingersoll & Rooney. Select healthcare business leaders will participate in a two-hour virtual roundtable discussion moderated by Stephen K. Klasko, M.D., M.B.A., President and CEO, Thomas Jefferson University and Jefferson Health. Topics will include insights to driving innovation, stakeholder perspectives, investment opportunities, and challenges relating to the future of digital healthcare. The goal of the roundtable is to have an interactive session where panelists can share meaningful insights and learnings with each other. Following the meeting, the discussion’s key insights, learnings, and implications will be summarized and shared with industry entities, as well as other key insight communications. “This event has been successful in years past and we’re excited for this year’s discussion given historic structural changes in healthcare delivery that we have observed over the last 15 months. It’s more important than ever to stay connected, for us as industry leaders and for policymakers, providers and consumers,” said Thomas Goss, PharmD, Senior Vice President, Boston Healthcare Associates. Edward Allera, Shareholder, Buchanan, Ingersoll & Rooney PC, agrees. “It’s beneficial for so many to produce meaningful collaborations when it comes to institutions, services, products, innovations and research. I’m happy to help create a platform to make this possible,” said Allera. Panelists will include: Amy Abernethy, M.D., Ph.D., Former Principal Deputy Commissioner & Acting CIO, FDA Tom Cassels, M.P.P, President, Rock Health Quinn Dufurrena, DDS, JD, Chief Dental Officer of United Concordia Dental Mark Haig Khachaturian, Ph.D., Chief Technology Officer, Wellvii Allison Oelschlaeger, BSFS, Director & Chief Data Officer, CMS Christopher T. Olivia, MD, Chief Executive Officer, Rothman Orthopaedic Institute Samantha (Mandy) J. Pulliam, MD, Chief Medical Officer, Renovia, Inc. Wendy Sanhai, Ph.D., M.B.A., Specialist Leader, Deloitte Consulting, FDA Richard Schwabacher, Senior Vice President of Digital Health and Chief Digital Officer, BioReference Laboratories, Inc. Michael Sherman, MD, M.B.A., Executive Vice President & Chief Medical Officer, Harvard Pilgrim Health Care and Tufts Health Plan “There’s so much talent and many bright minds in the life sciences industry. It’s crucial to bring this group together and give them the opportunity to share knowledge and introduce insights to their peers on a regular basis,“ said Timmy Garde, Chief Innovation Leader, LevLane. Attendance to the 4 th Annual Leaders in Life Sciences Breakfast Roundtable is limited. Please register at: LeadersInLifeSciences051821.com. Key insights will be released following the roundtable discussion. About Leaders in Life Sciences Leaders in Life Sciences is a partnership of LevLane, Boston Healthcare, and Buchanan, Ingersoll & Rooney PC. The group was formed to bring together thought leaders in the Life Science space to provide insights and solutions to the biggest challenges facing the industry. To learn more about Leaders in Life Sciences contact Timmy Garde at tgarde@levlane.com, Edward Allera at edward.allera@bipc.com, or Thomas Goss at tgoss@bostonhealthcare.com. Contact Details Liz Weir +1 610-401-4825 lweir@levlane.com Company Website https://www.levlane.com

May 14, 2021 07:01 AM Eastern Daylight Time

Image

SOCIETY OF UROLOGIC ONCOLOGY SHARES NEW PATIENT & CAREGIVER RESOURCES TO MARK BLADDER CANCER AWARENESS MONTH

Society of Urologic Oncology

The Society of Urologic Oncology (SUO) is sharing several new valuable resources for patients suffering from malignant genitourinary diseases like bladder cancer, and their caregivers. This release of a guidebook, documentary video, and public service announcements coincide with the designation of May as Bladder Cancer Awareness Month. The materials, made possible by funding support from Bristol Myers Squibb, feature Major League Baseball star pitcher and broadcaster, Jim Kaat. The resources offer information, help, comfort, and hope to those seeking more information about their health, and options following a diagnosis. “Nearly 68,000 people in the United States are impacted by bladder cancer every year, making it one of the most common cancers. It is also one of the deadliest cancers that will claim close to 18,000 lives in the US this year alone,” explained Dr. Michael Cookson, the President of the Society of Urologic Oncology. “Too often our patients learn about this disease upon diagnosis despite the warning signs. The resources we are sharing help patients and their caregivers navigate the best path forward for treatment and better health.” The SUO’s Guide to Advanced Bladder Cancer for Patients and Caregivers includes a 40-page guidebook and a companion (15-minute) documentary-style video. The guidebook is designed to help the reader better understand advanced bladder cancer, how it can be treated, and resources available to help improve health and well-being. Dr. Seth Lerner, a SUO physician, Chair of its Education Committee, and leader in the Bladder Cancer Advocacy Network stated, “These tools provide the information our patients, and the people who care for them need fight this disease. There are so many questions that come up along the way, and these resources will help them improve their lives in the exam room and at home too.” The video features SUO President Dr. Michael Cookson, Chair, Department of Urology, University of Oklahoma Health Sciences Center & The Stephenson Cancer Center; and Dr. Sima Porten, Associate Professor, Department of Urology, University of California, San Francisco. Also featured - speaking from the caregiver perspective - is Major League Baseball star pitcher and broadcaster Jim Kaat, who tells the moving story of his late wife’s battle with bladder cancer. “Patients and their loved ones need to understand they are not alone,” stated Dr. Sima Porten, a SUO physician and member of its Education Committee. “Having information about the disease, how it is treated, and what can be expected can provide peace of mind to those in the fight. Learning from others and sharing experiences is valuable to the physical and mental health of patients.” Additionally, public service announcements are being distributed to further promote the availability of these important resources. The thirty-second and one-minute versions of the PSA are available here: https://suonet.org/resources/patients.aspx “Receiving a diagnosis of advanced bladder cancer can be scary and overwhelming. Although it might seem impossible to sift through all the new information you are faced with, SUO physicians are committed to helping our patients though treatment and trustworthy resources like this guidebook and video,” Dr. Cookson continued. The materials were produced by Conrad & Associates, an organization committed to improving health literacy by bringing together medical professionals and organizations, celebrities, and pharma to create patient education programs on current health topics. In addition to resources for patients, the materials also offer guidance for caregivers – including the personal perspective from Jim Kaat who explains, “When you’re caring for a loved one, sometimes you neglect taking care of yourself. It’s very important for the caregiver to also take care of themselves.” ### The Society of Urologic Oncology (SUO) was founded in 1984 for the purpose of bringing together healthcare professionals to discuss, develop, and implement ideas to improve care for people with malignant genitourinary diseases like bladder cancer. The SUO hosts and sponsors programs designed to provide specific expertise in urologic oncology. The SUO’s research initiatives involve clinical trials through the SUO Clinical Trials Consortium. The SUO’s primary objectives are to: Encourage research and teaching in urologic oncology Bring awareness of urologic oncology to the larger medical profession Invite urologists into a society whose work is focused in malignant disease Be the most qualified organization on matters of urologic oncology Create standards for professional training in urologic oncology Please visit https://suonet.org/home.aspx For more information or to schedule an interview with a SUO spokesperson, please contact Dan Rene of kglobal at 202-329-8357 or daniel.rene@kglobal.com Contact Details kglobal Dan Rene +1 202-329-8357 daniel.rene@kglobal.com Company Website https://suoctc.org/about.aspx

May 13, 2021 02:30 PM Eastern Daylight Time

LOOMIS Delivers a Dozen Awards for Texas Oncology Ad Campaign

LOOMIS

The LOOMIS Agency delivered big for client Texas Oncology, taking home 12 awards at the 38 th Annual Healthcare Advertising Awards show, including the Gold Award for “Total Advertising Campaign.” The agency won five Gold, one Silver, four Bronze and two Merit awards for its “Right Here” campaign. “We are so pleased with the recognition,” said Steven Paulson, M.D, president and chairman of Texas Oncology. “The ‘Right Here’ campaign has been very well received by all of our stakeholders because it does a wonderful job communicating our important difference as a provider of oncology treatment and care.” Texas Oncology’s 500+ physicians deliver leading-edge cancer care at its 210 locations in communities across the state, so patients don’t have to travel far from home to receive the expert treatment they need. “That’s a big difference for Texas Oncology patients and it’s the basis of our campaign,” said LOOMIS account director Christina McKinney. “With Texas Oncology, patients don’t have to disrupt their lives to get the care they need,” McKinney said. “They can stay at home surrounded by the love and support of family and friends.” The campaign launched January 1, 2021 and is running statewide across all major media channels, including television, digital display and video, print, outdoor, search and social. There were more than 4,400 entries for this year’s Annual Healthcare Ad Awards, making it the largest healthcare advertising awards competition and placing it among the top 10 advertising awards shows in the country. About LOOMIS: LOOMIS is a full-service advertising agency in Dallas specializing in defining and leveraging strategic advantages for national and regional challenger brands. The agency was founded in 1984 by Paul Loomis, a composer and musician who earned a national reputation for brand-image music development. The agency was expanded in 1998 to meet growing client demand. Today, LOOMIS offers clients a unique blend of advertising and music production. Learn more at theloomisagency.com. About Texas Oncology: Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 90 FDA-approved therapies, about one-third of all cancer therapies approved to date. For more information, visit TexasOncology.com. Contact Details LOOMIS Lauren Law +1 214-912-1543 lauren.law@theloomisagency.com Company Website https://theloomisagency.com

May 13, 2021 09:15 AM Eastern Daylight Time

Video Image

LevLane Announces Multiple Promotions and Role Changes

LevLane

LevLane, a full-service, award-winning ad agency, now in its 37th year, has announced multiple promotions as the agency continues to see strong growth. “We are so proud of this team. Over the past year we have experienced challenges we never anticipated and despite that our team has continued to deliver,” said Josh Lev, SVP | Brand Engagement of LevLane. “As we emerge from one of the most difficult times in memory, we are excited to look to the future and the team who will help to get us there.” Web Development Megan Hegarty has been promoted to Vice President, Digital Services. Senior Living Beth Simos has been promoted to Vice President, Director of Client Engagement. Creative Taylor Irwin has been promoted to Associate Creative Director. Steven Graziano has been promoted to Senior Art Director. Joe Schoppy has been promoted to Senior Copywriter. Digital Media Ed Stec has been promoted to Vice President, Paid Search Director. Sarita Shinde has been promoted to Digital Analytics Manager. Life Sciences MaryPat Siwak has been promoted to Account Director. Gina Gattis has been promoted to Account Supervisor. Samantha Spurrier has been promoted to Account Executive. Content & Digital Strategy Gabrielle Costello has been promoted to Director of Content. Michele Burns has moved into the role of Content Project Manager. Tyler Heileman has moved into the role of Digital Content Writer. Emily Glorioso has moved into the role of Social Media Specialist. About LevLane LevLane is an award-winning, full-service, independent advertising agency in Philadelphia, PA that has been building brands that people love for nearly 40 years. Contact Details LevLane Liz Weir +1 610-401-4825 lweir@levlane.com Company Website https://www.levlane.com

May 13, 2021 07:06 AM Eastern Daylight Time

Image

MISSOURI GOP LEGISLATOR URGED BY PHYSICIAN & PATIENT ADVOCACY ORGANIZATIONS TO ABANDON PLAN TO THWART PHARMACY BENEFIT MANAGER ACCOUNTABILITY

Alliance for Transparent & Affordable Prescriptions

Today the Alliance for Transparent and Affordable Prescriptions (ATAP) released a letter sent on behalf of its membership to Eric Burlison, a Missouri State Senator requesting he abandon a plan to allow the pharmacy benefit manager (PBM) industry continue its abusive practices and jeopardize patients. Following up on information that Senator Burlison is planning to filibuster legislation including HB 834 and its companion bill SB 403 this week, concerns in the medical and patient advocacy community are growing – and many are voicing major concerns. “If successful, Senator Burlison’s filibuster will eliminate accountability on the PBM industry and place upward pressure on prescription drug pricing,” stated Dr. Robert Levin, ATAP President. “For far too long, PBMs generated significant profits while patients struggle to afford the cost of prescription drugs. It is time that elected officials and policymakers see what is really happening in our exam rooms and our patient’s wallets due to PBM interference.” ATAP has been an active advocate for patients in a variety of federal and state battles to amplify the voices of patients and physicians. The letter to Senator Burlison states, in part: “…the Trump administration proposed a rule through Health and Human Services (HHS), that would have eliminated the safe harbor that protects PBM rebates from the federal anti-kickback statute. This awesome proposal would have effectively eliminated the PBM rebate system… Regrettably, the new administration withdrew this essential patient protection. States can play a central role to ensure that patients are still protected from abusive PBM practices…” “A light is finally shining on the previously hidden profit motives of the PBM industry. Patients, physicians, and policymakers in Missouri have the power to effect meaningful change if Senator Burlison allows this legislation to be considered fairly,” Dr. Levin continued. “More transparency is desperately needed in the PBM industry, and this legislation provides it. It is truly a mystery why any elected official would prevent such accountability and stand in the way of fair drug prices and patient access to care.” The full letter to Senator Burlison is below and posted here. The Honorable Eric Burlison 201 W Capitol Ave., Rm. 221 Jefferson City, Missouri 65101 RE:MO HB 834 and SB 403 – Pharmacy Benefit Managers Reporting/Transparency Dear Senator Burlison: We are saddened and dismayed to learn of your recent stance regarding Missouri HB 834. We are painfully aware of a planned filibuster to MO HB 834 and its companion bill SB 403. As you may be aware, Pharmacy Benefit Managers (PBMs) are third-party entities that are hired by insurers and health plan sponsors to manage and administer prescription drug benefit plans. We are very concerned about the role PBMs play regarding the alarming price increases in the total cost and out of pocket costs of prescription drugs for patients, resulting in the loss of patient access to affordable and life-saving medications. HB 834 will help remedy many of these practices by: Ensuring oversight of PBMs by the Dir. of the MO Dept of Commerce and Insurance; Allowing for penalties for violations of this statute; Providing for reporting of rebates received by PBMs, including – where the rebates are being applied, and reporting of yearly aggregated rebate dollar amounts received; and Providing for freedom of choice for patients to choose their pharmacy As you may know, the Trump administration proposed a rule through Health and Human Services (HHS), that would have eliminated the safe harbor that protects PBM rebates from the federal anti-kickback statute. This awesome proposal would have effectively eliminated the PBM rebate system. Regrettably, the new administration withdrew this essential patient protection. States can play a central role to ensure that patients are still protected from abusive PBM practices. We ask that you help ensure that our patients and your constituents have affordable access to the medications which they so desperately need, by supporting MO HB 834 and its companion bill SB 403. Sincerely, The Alliance for Transparent and Affordable Prescriptions (ATAP) Member Organization ### ATAP continues to support efforts to force the PBM industry to disclose rebate data and encourage transparency and reporting requirements for all entities involved in the prescription drug supply chain – PBMs, insurers, and manufacturers. To schedule an interview with Dr. Levin or another ATAP spokesperson, please contact Dan Rene of kglobal at 202-329-8357. Please visit http://www.atapadvocates.com ATAP's mission is to address prescription drugs costs and patient access to affordable treatment by regulating PBM practices and reforming the drug industry through educational outreach and grassroots advocacy initiatives at both the state and federal level. Contact Details Dan Rene +1 202-329-8357 daniel.rene@kglobal.com Company Website http://www.atapadvocates.com

May 12, 2021 05:00 PM Eastern Daylight Time

Video On Demand Technology Provider Intelivideo and CIPIO Partner to Increase Customer Retention in the Hybrid B2C Subscription Economy

CIPIO.ai

CIPIO, a B2C Subscription Customer Success company, today announced the start of a strategic partnership with Intelivideo, a Video on Demand (VOD) and Livestreaming digital platform provider for gyms, health clubs, and fitness operators. The partnership empowers Intelivideo’s customers with unmatched visibility and actionable intelligence into subscriber behavior, helping them increase subscriber engagement while proactively preventing churn. The partnership will enable Intelivideo’s customers to acquire a competitive advantage in the rapidly transforming fitness market, fighting its way through the impact of the COVID-19 global pandemic. In today’s fitness market, where 76% of all consumers have had to switch to at-home workouts to accommodate the constraints of social distancing, Intelivideo has helped brick-and-mortar gyms and health clubs rapidly transform themselves to serve the needs of customers, in the process solidifying its role as a frontrunner in the digital fitness space. “Our customers have a significant amount of data and customer signals. CIPIO's capability to package those signals up in Data Apps with hyper-personalized predictions and recommendations for the digital subscriber is a game-changer” said Adam Zietsiff, President and CEO of Intelivideo. “We are very excited to partner with CIPIO to help our customers grow exponentially by providing them with predictive recommendations to proactively prevent subscriber churn – thus closing out a critical loop when it comes to retaining subscriptions.” To move beyond the BI and AI status quo, health club operators need solutions that help them deliver real business value instead of getting them stalled by technology and implementation hurdles. CIPIO eliminates all the bottlenecks from Data to ROI, thus accelerating time to value for businesses. With over two million subscriber churn-specific algorithms and nearly code-free building blocks, CIPIO’s Data Apps use AI to unify all the siloed data lifecycle steps, operationalize automated workflows, and recommend insights directly into engagement systems. This empowers fitness stakeholders and non-technical users across levels to rapidly uncover trends and engagement patterns and make timely decisions to delight subscribers across all channels and devices consistently. “Following the pandemic, health and fitness are more important to consumers than ever before. We are obsessed with helping fitness operators with the critical task of serving the health and wellness crises that the COVID pandemic has created,” said Growson Edwards, CEO of CIPIO. “CIPIO’s Domain-Infused Data Apps Platform™ arms health club operators with unprecedented customer intelligence aimed at enhancing subscriber engagement and retention for continued growth.” CIPIO’s entry into the OTT market could not have happened at a better time when the segment is witnessing skyrocketing demand for media and entertainment, virtual fitness, elearning, and gaming. CIPIO’s Domain-Infused Data Apps helps OTT players manage subscription fatigue and offers incentivized retention recommendations to increase member loyalty and minimize churn. About Intelivideo: Established in 2013, Intelivideo is a Video On Demand (VOD) and digital technology platform for gyms and health clubs. Intelivideo is committed to developing strong partnerships with the fitness industry to help deliver premium on-demand and livestreaming experiences to clients' member bases. The platform's end-to-end solution helps clubs build a successful Subscription Video On Demand (SVOD) business to complement brick-and-mortar facilities and services, helping them differentiate themselves from disruptive third-party digital fitness offerings in a hyper-local, hybrid fashion. About CIPIO: CIPIO is pioneering the Industry's first domain-infused Data Apps Platformâ¢ that humanizes and automates predictions and recommendations to increase Subscriber engagement, retention, and growth for B2C Subscription Companies. CIPIO's early adopters include Crunch Fitness, Industry's Gym, Xponential Fitness, Motor City Church, Pure Barre, Club Pilates, AKT, YogaSix, NCFit, Cyclebar, RowHouse, Stretch Lab, and Stride who have witnessed a significant return on investment in a short time. Contact Details CIPIO Chris Foudy +1 831-238-1905 chris@cipio.ai Company Website https://cipio.ai/

May 12, 2021 12:00 PM Eastern Daylight Time

City of New York, Largest City in the US, to use Shatterproof’s Online Addiction Training as a Resource for Employees and their Families

Shatterproof

Today, the City of New York has made Shatterproof’s Just Five, an online education program about the disease of addiction, available to more than 335,000 employees and their families. Just Five is a self-paced, mobile-enabled program focused on increasing awareness, reducing stigma, and sharing important information about addiction prevention and treatment. It is available in both English and Spanish languages. Participants will learn who is at risk, how to discern whether a person has a substance use disorder, how to support loved ones with this disease, and more. Just Five includes six guided learning experiences that combine animated and expert videos, interactive learning, and supplemental materials. All lessons are woven together with a positive message that change is possible for everyone. “We are extremely proud to have the largest city in the United States, New York City, use Just Five to educate their employees” said Shatterproof Executive Vice President, Stephen D’Antonio. “Nearly one hundred million people in the US are impacted by substance use disorders, whether it is themselves or a loved one. Just Five provides easy access to critical information and resources giving employers and communities a simple and scalable tool to deliver both.” “NYC recognizes that substance misuse and addiction is a public health crisis.  We are committed to ensuring that all of our employees and their families have access to information, education, high quality treatment and support.  Just Five will be an excellent and accessible complement to our Employee Assistance Program, our unions’ member assistance programs and our WorkWell NYC health and well-being programs,” said Renee Campion, Commissioner, NYC Mayor’s Office of Labor Relations. Rates of addiction and overdoses are at the highest ever seen in the United States in the wake of the COVID-19 pandemic. The CDC recently reported that between August 2019 and August 2020 nearly 90,000 people died on an overdose and those numbers are expected to rise. If you would like to learn more about this program, including how to make it available, please visit www.justfive.org or email justfive@shatterproof.org. About Shatterproof: Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the United States. Shatterproof harnesses the models of business, the rigor of science and the power of a national movement to create change and save lives through three pillars of work: revolutionizing the addiction treatment system, breaking down addiction-related stigmas and supporting and empowering our communities. To learn more visit www.Shatterproof.org. Contact Details Holly Jespersen +1 646-334-1024 hjespersen@shatterproof.org Company Website https://www.shatterproof.org/

May 12, 2021 09:17 AM Eastern Daylight Time

LevLane Announces Hiring of Chief Talent Officer, Adam Heagy

LevLane

LevLane announced today that it has hired Adam Heagy as its new Chief Talent Officer. Heagy is an experienced leader in HR and talent acquisition and development, and a veteran of the advertising talent world. Prior to joining LevLane, Heagy was President of Interactive Recruiting Consultants for nearly 10 years where he led all recruiting and talent efforts. “We’ve worked with Adam for years as our contract recruiter and he’s always been a true partner, providing reliable guidance and sending us fantastic talent,” said Josh Lev, SVP Brand Engagement at LevLane. “It was a natural fit to bring Adam into the LevLane family full-time to help us find the best talent for our future growth.” While at Interactive Recruiting Consultants, Heagy worked with a wide range of advertising and marketing agencies to source and recruit top talent. “LevLane has a phenomenal culture that is truly unique in the advertising world, said Heagy. “So, when the opportunity arose to join the team full-time, it was a no-brainer. I’m excited to be part of such a talented team and can’t wait to find that next generation of LevLane talent.” Heagy will be responsible for all talent acquisition and will head up the Human Resources Department, reporting to Chief Financial Officer, Nicole Landau. --- About LevLane LevLane is an award-winning, full-service, independent advertising agency in Philadelphia, PA that has been building brands people love for nearly 40 years. Contact Details LevLane Liz Weir +1 610-401-4825 lweir@levlane.com Company Website https://www.levlane.com

May 12, 2021 07:56 AM Eastern Daylight Time

Image

GROUNDWORK BIOAG RAISES $11 MILLION TO ADVANCE BIOAGRICULTURE GLOBALLY

Groundwork BioAg

Accelerating Production Capacity to Meet Demand for Regenerative Agriculture Products Serving One Million Acres (400 KHa) in 2021 Groundwork BioAg announced today it raised $11 million in venture capital financing led by Ibex Investors with the participation of ProDelta and Future Foodways. Previous investors, including MoreVC, Middleland Capital, Axess Ventures and BPD Agri, materially participated in the round. With this new funding, Groundwork BioAg will accelerate and expand production of its mycorrhizal platform to meet global demand for natural, sustainable solutions that increase agricultural productivity while preserving soil health. Groundwork BioAg, a global bioagriculture technology company, produces highly effective mycorrhizal inoculants. Mycorrhizae are a cornerstone of regenerative agriculture best practices. In addition to increasing yields, these natural products reduce dependency on phosphorus fertilizer and improve carbon sequestration in soil. Through distribution partnerships in strategic markets across five continents, the company is helping farmers improve the efficiency of major crop production, including corn, soybeans, grains, bio-energy crops, fruits and vegetables, and cannabis. “Over the past few years, we have focused on building production capacity to support millions of hectares and solidify our global presence in the main agricultural markets. With this investment and strong sales, we will be able to fulfill our mission to bring mycorrhiza – the queen of biologicals – to mainstream agriculture and help farmers succeed while protecting our planet,” said Dr. Yossi Kofman, Co-Founder and CEO of Groundwork BioAg. “We look forward to working with our investors, strategic partners and distributors to continue bringing meaningful value to farmers around the world.” While naturally occurring in the Earth’s soil, mycorrhizae and other beneficial microbes have been destroyed by modern farming practices, including tilling, pasteurization and over fertilization. Following years of research and product development, Groundwork BioAg is the first to crack the code on mass production of highly concentrated, cost-effective mycorrhizal inoculants that improve yield and soil health. The company’s flagship products include Rootella® for commodity, organic and specialty crops, and DYNOMYCO® for cannabis. Following record sales in both the 2019 and 2020 growing seasons, the company is rapidly scaling up production to meet demand expected in 2022 and beyond. Approximately one million acres (400 Kha) will benefit from the company’s unique products in 2021. Disruptive Technology VC Chooses Groundwork BioAg As First Investment in AgTech “We are pleased to add Groundwork BioAg to our portfolio – not only because of its strong in-field performance and continued growth trajectory, but also because its technology provides the most compelling solution to increase yield while protecting our environment,” said Gal Gitter, Managing Director of Ibex Investors focused on growth stage investments. “With its high efficacy and broad applicability, Groundwork BioAg can feasibly treat over one billion hectares, nearly all of the world’s farmland, with these beneficial fungi.” Headquartered in Denver, Colorado with offices in Tel Aviv and New York, Ibex Investors is a multi-strategy investment firm targeting outsized returns through differentiated global strategies. Ibex invests internationally in Israel, which has the highest concentration of start-up companies outside Silicon Valley. The funding demonstrates Groundwork BioAg’s strong growth position and enables efforts to expand its platform technology and accelerate production capacity to meet global demand for regenerative agriculture products. About Groundwork BioAg Groundwork BioAg, a global bioagriculture company, leverages the natural power of mycorrhizal fungi to improve the productivity, sustainability and profitability of commercial agriculture and expand regenerative agriculture practices. Groundwork BioAg is the first to use innovative techniques to solve challenges inherent in high-volume mycorrhizal inoculant production. We will not rest until every hectare of arable land is protected by mycorrhizae and every farmer benefits from higher crop yields while preserving our soils. For more information, visit http://www.groundworkbioag.com Contact Details AgTech PR for Groundwork BioAg Jennifer Goldston +1 816-260-0040 jennifer@agtechpr.com Company Website https://www.groundworkbioag.com

May 12, 2021 07:00 AM Eastern Daylight Time

1 ... 273 274 275 276 277 ... 304